For Immediate Release
Chicago, IL – January 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc.
GOOGL
, salesforce.com, inc.
CRM
, and Starbucks Corporation
SBUX
.
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Alphabet, salesforce and Starbucks
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Alphabet Inc., salesforce.com, inc., and Starbucks Corporation. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
all of today’s research reports here >>>
Shares of
Alphabet
have outperformed the S&P 500 over the past year (+55.3% vs. +25.8%). The Zacks analyst believes that Alphabet’s dominant search market share, an expanding cloud footprint and strengthening presence in the smart home market are the major catalysts for the stock’s continued outperformance.
Google’s mobile search has been gaining solid momentum. Strong focus on innovation of AI techniques as well as wearables technology is likely to aid business growth in the long term. Alphabet’s expanding presence in the autonomous driving space is another major positive. Growing litigation issues and increasing expenses, however, are concerning.
(You can
read the full research report on Alphabet here >>>
)
salesforce
shares have lost -17.1% over the past three months against the Zacks Computer Software industry’s gain of +2.9%. Stiff competition, unfavorable currency fluctuations as well as increasing investments in international expansions and data centers are some of the major headwinds for CRM.
The Zacks analyst, however, believes that salesforce has been benefiting from a robust demand environment amid a major digital transformation. The rapid adoption of its cloud-based solutions is driving demand for its products. The recent acquisition of Slack is likely to position salesforce as a leader in the enterprise team collaboration solution space, thereby enabling it to better compete with Microsoft’s Teams product.
(You can
read the full research report on salesforce here >>>
)
Shares of
Starbucks
have lost -4.9% in the last six months against the Zacks Food & Restaurants industry’s loss of -1.9%. SBUX’s earnings in fiscal 2022 is likely to be impacted by strategic investments and cost inflation. Earnings estimates for 2022 have declined in the past 60 days.
The Zacks analyst, however, believes that store growth, robust digitalization initiatives and a sturdy comps growth bode well for the long term. Starbucks’ also reported impressive U.S. comps for the third straight quarter in fourth-quarter fiscal 2021. SBUX now anticipates global comparable sales to reach high-single digits in fiscal 2022.
(You can
read the full research report on Starbucks here >>>
)
Other noteworthy reports we are featuring today include Amgen Inc. (
AMGN
), BP p.l.c. (
BP
) and Fidelity National Information Services, Inc. (
FIS
).
Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?
From inception in 2012 through November, the
Zacks Top 10 Stocks
gained an impressive +962.5% versus the S&P 500’s +329.4%. Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.
Be First To New Top 10 Stocks >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report